CSS
VIGL

Cubist Systematic Strategies’s Vigil Neuroscience VIGL Stock Holding History

Cubist Systematic Strategies’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,161
Closed -$27K – 3556
2025
Q1 		$27K Sell
15,161
-8,959
-37% -$20.1K ﹤0.01% 2731
2024
Q4 		$41K Buy
24,120
+8,358
+53% +$24.7K ﹤0.01% 2800
2024
Q3 		$53.6K Buy
15,762
+12,109
+331% +$44.9K ﹤0.01% 2758
2024
Q2 		$14.6K Buy
+3,653
New +$12.5K ﹤0.01% 2782
2022
Q3 		– Sell
-1,118
Closed -$3K – 4751
2022
Q2 		$3K Buy
1,118
+118
+12% +$466 ﹤0.01% 4313
2022
Q1 		$7K Buy
+1,000
New +$13.2K ﹤0.01% 3504

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Cubist Systematic Strategies's VIGL Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of Vigil Neuroscience (VIGL) in Q2 2025, closing a stake of 15,161 shares — an estimated $27K sold.

Cubist Systematic Strategies first reported a position in VIGL in Q1 2022 and held it in 6 quarters. The position peaked at $53.6K in Q3 2024. 78 funds tracked by Wall St. Rank hold VIGL as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining Vigil Neuroscience position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 15,161 Vigil Neuroscience shares in Q2 2025, an estimated $27K.
  • Cubist Systematic Strategies first reported a position in Vigil Neuroscience in Q1 2022 and held it in 6 quarters.
  • Cubist Systematic Strategies's Vigil Neuroscience position peaked at $53.6K in Q3 2024.
  • 78 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.